Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

67.48 +0.50 (+0.75%)
Streaming Delayed Price Updated: 12:46 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bristol-Myers Squibb

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
26 27 Next >
Boeing, Meta Platforms And 5 Stocks To Watch Heading Into Wednesday
With US stock futures trading higher this morning on Wednesday ahead of earnings reports from several big companies, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Tuesday's Market Minute: Tech Heavyweight Earnings On Deck: GOOGL, MSFT, META, AMZN, AAPL
U.S. equities wobbled to start arguably the busiest week of earnings of the quarter. Monday kicked off the final week of trading for the month of July, and despite initial overall weakness... 
Via Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
Big tech earnings will flow in thick and fast in the upcoming week, providing more clarity on how supply chain disruptions and the macroeconomic malaise have impacted these companies. 
Via Benzinga
3 Blue Chip Stocks For Reliable Dividends
Stocks that have proved resilient to recessions and offer reliable dividends, with a wide margin of safety. 
Via Talk Markets
7 Best Cash Cow Stocks to Buy for Stable Returns
These shares are among the best cash cow stocks to buy now. AZO, BMY, CSCO, KLAC, KR, MCK, and MRNA can make great investments. 
Via InvestorPlace
Recap Of Friday's Biotech Catalysts - End Of The Day Summary
 
Via Benzinga
Earnings Preview: Bristol Myers Squibb Q2 Earnings Expected to Decline
Bristol Myers Squibb is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2022. 
Via Talk Markets
7 Best Pharmaceutical Stocks to Buy Now
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world. 
Via InvestorPlace
Recession-Proof Stock Of The Week: Eli Lilly
Few sectors can withstand the economic headwinds that come during periods of economic upheaval, including recession and inflation. Recession stocks are sought out by retail and institutional investors... 
Via Talk Markets
Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know
Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras. 
Via Benzinga
Best Stocks for 2022: After Two Quarters, Who Holds The Lead?
After the first two quarters of fiscal year 2022, who holds the top spot in the InvestorPlace Best Stocks for 2022 contest? Let's dive in. 
Via InvestorPlace
Aurinia Pharmaceuticals Skids With Its Buyout Thesis Hanging By A Thread
The company just hired three new executives, likely putting a buyout in the rearview. 
Via Investor's Business Daily
Looking Into Bristol-Myers Squibb's Recent Short Interest
Bristol-Myers Squibb's (NYSE:BMY) short percent of float has risen 12.88% since its last report. The company recently reported that it has 38.98 million shares sold short, which... 
Via Benzinga
Bristol-Myers Squibb Whale Trades For July 12
Someone with a lot of money to spend has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Best Stocks for 2022: Bristol-Myers Squibb
BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow. 
Via InvestorPlace
Biotech Stocks To Watch And Pharma Industry News
Track the latest trends and leading stocks in the biotech and pharmaceutical industries. 
Via Investor's Business Daily
Bristol-Myers Squibb Whale Trades For July 07
Someone with a lot of money to spend has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
6 Stocks Hedge Funds Love in a Recession
6 stocks hedge funds love in a recession, including the top 3 holdings from Michael Burry and Leon Cooperman. 
Via InvestorPlace
Changing The Landscape Of Cancer Therapy With Macrophages? How One Israeli Company Reports It's Looking To Do Just That
One of the chief challenges cancer researchers face today is finding a way to outsmart the disease’s defense mechanisms. 
Via Benzinga
CNBC's Final Trades: These 2 Health Care Majors, Verizon Communications And iShares 7-10 Year Treasury Bond ETF
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Verizon Communications Inc. (NYSE: VZ) is trading at nine times earnings 
Via Benzinga
Hot Stocks: Tickers Moved By Traders on 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment. 
Via Benzinga
This Is What Whales Are Betting On Bristol-Myers Squibb
A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 12 strange trades. 
Via Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
5 S&P 500 Stocks Ready to Break Out
Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out. 
Via InvestorPlace
Looking Into Bristol-Myers Squibb's Recent Short Interest
Bristol-Myers Squibb's (NYSE:BMY) short percent of float has risen 4.49% since its last report. The company recently reported that it has 34.46 million shares sold short, which is... 
Via Benzinga
New York Judge Denies Bristol Myers Claim To Dismiss Lawsuit Over Delayed Cancer Drug Approval: Reuters
 
Via Benzinga
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up
Shockwave and UnitedHealth lead 5 stocks that are setting up or breaking out. 
Via Investor's Business Daily
This Is What Whales Are Betting On Bristol-Myers Squibb
Someone with a lot of money to spend has taken a bullish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.